news
stories from the front lines of discovery
From scientific breakthroughs to new open‑source tools, the Allen Institute’s work is reshaping how science is done—and who it’s for. Explore the latest news, stories, and highlights from across our research, partnerships, and open science efforts.
Brain Health accelerator to transform our understanding of brain disorders and develop new treatments
The global collaborative research initiative will initially target Alzheimer’s, Parkinson’s, Huntington’s disease, ALS, and Lewy body dementia
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Science is...
Science is everywhere. Science is all of us. See what science is to our Allen Institute team.
No items found.
video
5 cool things your immune system can do
Hack evolution, keep lifelong exposure records and more - immunologists share some of the far-out cellular feats happening in your body on a regular...
No items found.
news
Cytiva licenses Allen Institute’s advanced machine learning technology to develop new cell imaging techniques
Strategic license to advance the field of 3D and live cell imaging
No items found.
news
Could treatments aimed at Alzheimer’s disease help combat COVID-19?
A team of cardiology researchers had a creative idea for a new way to treat dementia. Now they think it could help coronavirus patients too.
No items found.
news
A new approach to Alzheimer’s disease research
Most efforts to treat Alzheimer's disease simply haven't worked. That's why leading researchers in Seattle are teaming up with us to study early...
No items found.
video
Team science in the era of remote work
As the COVID-19 pandemic dictates physical distance and many scientists are working from home, how can teams pivot to pull off coordinated research...
No items found.
news
Old age changes the way blood accesses the brain
A new study in mice shows that contrary to longstanding dogma, blood proteins easily cross into the brain, but transport machinery breaks down with ag...
No items found.
news
The Leukemia & Lymphoma Society, The Mark Foundation for Cancer Research and The Paul G. Allen Frontiers Group Partner to Award $6.75M in New Grants to Drive the Next Wave of Novel Cancer Therapies
New “Blood Cancer Discoveries Grant Program” supported by a novel three-way collaboration
No items found.
news
Seattle researchers team up to build hi-res brain map of Alzheimer's disease
$40.5M NIH-funded project aims to pinpoint cells at the root of the progressive brain disease and home in on new therapeutic targets
No items found.
news
Cell Shorts | Lab-grown human skin holds promise for skin grafts
Researchers have succeeded in growing the most lifelike human skin in the lab to date. Allen Institute for Cell Science cell lines formed the basis...
No items found.
news
No results found, try reducing your search parameters.
press & media contact
Get in touch for media inquiries and resources for covering science at the scale of greatest impact.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
The Paul G. Allen Frontiers Group UC Berkeley's Jennifer Doudna a New Allen Distinguished Investigator
The Paul G. Allen Frontiers Group today named Jennifer Doudna, Ph.D., at the University of California, Berkeley an Allen Distinguished Investigator (ADI) with an award for “Antiviral Machinery and Cell Editing Platforms” at the frontier of RNA targeting and cell editing.
No results found, try reducing your search parameters.
